Literature DB >> 11453053

Relevance of 99mTc-MIBI rest uptake, ejection fraction and location of contractile abnormality in predicting myocardial recovery after revascularization.

J M González1, J Castell-Conesa, J Candell-Riera, J Rosselló-Urgell.   

Abstract

The aim of this study was to analyse the influence of rest technetium-99m-methoxy-isobutyl-isonitrile (99mTc-MIBI) uptake, left ventricular ejection fraction (EF) and dysfunctional location in the prediction of myocardial viability. Rest 99mTc-MIBI single photon emission computed tomography (SPECT) was analysed in 82 patients (59+/-9 years, 70 men, 12 women) with one or more segments showing severe hypokinesia, akinesia or dyskinesia who had undergone coronary revascularization. Before and within 3-6 months after the revascularization, gated blood pool scintigraphy was performed. In the post-revascularization control, contractile recovery was observed in 48.7% (155/318) of the segments with severe hypokinesia, akinesia or dyskinesia. Significant increases in sensitivity (53%, 72% and 91%, P<0.0001) and negative predictive value (62%, 68% and 79%, P = 0.01) were observed with decreasing rest uptake 99mTc-MIBI levels of 50%, 40% and 30%, respectively. The decrease in specificity was also significant (67%, 53% and 32%, P<0.0001). The negative predictive value was higher than the positive predictive value mainly in patients with EF < or = 0.35 and with anterior dysfunction. In logistic regression analysis, uptake levels and EF were independent variables that influenced sensitivity and specificity. The negative predictive value was influenced by EF and the positive predictive value only by dysfunctional location. This study suggests that the negative predictive value of 99mTc-MIBI SPECT is higher than the positive predictive value, mainly in patients with EF < or = 0.35, and that the rest uptake level, EF and dysfunctional location are factors that must be considered when results of 99mTc-MIBI SPECT are analysed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453053     DOI: 10.1097/00006231-200107000-00011

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  5 in total

1.  Mortality risk associated with ejection fraction differs across resting nuclear perfusion findings.

Authors:  Jamieson M Bourque; Eric J Velazquez; Robert H Tuttle; Linda K Shaw; Christopher M O'Connor; Salvador Borges-Neto
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

2.  Clinical characteristics and referral pattern of patients with left ventricular dysfunction and significant coronary artery disease undergoing radionuclide imaging.

Authors:  Jamieson M Bourque; Eric J Velazquez; Salvador Borges-Neto; Linda K Shaw; David J Whellan; Christopher M O'connor
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

3.  Prognostic value of myocardial perfusion-gated SPECT in patients with ischemic cardiomyopathy.

Authors:  Jaume Candell-Riera; Guillermo Romero-Farina; Santiago Aguadé-Bruix; Joan Castell-Conesa; Gustavo de León; David García-Dorado
Journal:  J Nucl Cardiol       Date:  2009-01-22       Impact factor: 5.952

4.  Analysis of apical remodeling in gated myocardial perfusion SPECT imaging in ischemic cardiomyopathy.

Authors:  Guillermo Romero-Farina; Jaume Candell-Riera; Santiago Aguadé-Bruix; Joan Castell-Conesa; Gustavo de León
Journal:  J Nucl Cardiol       Date:  2008 Mar-Apr       Impact factor: 3.872

Review 5.  Myocardial perfusion scintigraphy: the evidence.

Authors:  S R Underwood; C Anagnostopoulos; M Cerqueira; P J Ell; E J Flint; M Harbinson; A D Kelion; A Al-Mohammad; E M Prvulovich; L J Shaw; A C Tweddel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.